Article info
Asthma
Original research
CEACAM3 decreases asthma exacerbations and modulates respiratory syncytial virus latent infection in children
- Correspondence to Professor Yungling L Lee, Institute of Biomedical Sciences, N343, Academia Sinica, Taipei, Taiwan; leolee{at}ibms.sinica.edu.tw
Citation
CEACAM3 decreases asthma exacerbations and modulates respiratory syncytial virus latent infection in children
Publication history
- Received September 24, 2019
- Revised April 15, 2020
- Accepted May 5, 2020
- First published June 30, 2020.
Online issue publication
September 01, 2022
Article Versions
- Previous version (17 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.